• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prognostic significance of the DNA content of human breast cancer.

作者信息

Dowle C S, Owainati A, Robins A, Burns K, Ellis I O, Elston C W, Blamey R W

出版信息

Br J Surg. 1987 Feb;74(2):133-6. doi: 10.1002/bjs.1800740221.

DOI:10.1002/bjs.1800740221
PMID:3815031
Abstract

The DNA content of paraffin embedded primary tumour tissue has been measured by flow cytometry in 354 patients with operable breast cancer. Tumour ploidy significantly correlated with tumour size, histological grade, and with menopausal status. No significant correlation with oestrogen receptor status or lymph node involvement was found. Patients with diploid cancers had a significantly improved short term survival and disease-free interval (DFI) compared with patients having aneuploid tumours. However, no difference in survival or DFI was shown after longer term follow-up (median 84 months). Multivariate analysis showed no independently significant prognostic value for tumour ploidy. No patient in this study received adjuvant therapy.

摘要

相似文献

1
Prognostic significance of the DNA content of human breast cancer.
Br J Surg. 1987 Feb;74(2):133-6. doi: 10.1002/bjs.1800740221.
2
Tumour DNA ploidy as an independent prognostic factor in breast cancer.肿瘤DNA倍体作为乳腺癌的独立预后因素
Br J Cancer. 1987 Nov;56(5):637-42. doi: 10.1038/bjc.1987.258.
3
Tumour aneuploidy, prognostic parameters and survival in primary breast cancer.原发性乳腺癌中的肿瘤非整倍体、预后参数与生存情况
Br J Cancer. 1987 Apr;55(4):449-54. doi: 10.1038/bjc.1987.88.
4
DNA analysis of breast cancer by flow cytometry & correlation with other prognostic parameters.通过流式细胞术对乳腺癌进行DNA分析及其与其他预后参数的相关性
Indian J Med Res. 1992 Aug;96:223-9.
5
Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.乳腺癌中DNA倍体和细胞增殖的短期意义:对308例患者预后标志物的多变量分析
J Clin Pathol. 1999 Aug;52(8):604-11. doi: 10.1136/jcp.52.8.604.
6
Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.DNA 流式细胞术在局部复发、接受保守治疗的乳腺癌患者中的预后价值。
J Clin Oncol. 1992 Dec;10(12):1839-47. doi: 10.1200/JCO.1992.10.12.1839.
7
[Prognostic significance of cellular DNA ploidy level of the breast cancer].
Zhonghua Wai Ke Za Zhi. 1992 Jan;30(1):35-7, 63.
8
The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer.通过DNA图像细胞术测定乳腺癌DNA含量的预后意义:高度非整倍体在淋巴结阴性乳腺癌中的作用。
J Clin Pathol. 2007 Jun;60(6):649-55. doi: 10.1136/jcp.2005.035550.
9
Prognostic value of DNA ploidy status in patients with rectal cancer.DNA倍体状态在直肠癌患者中的预后价值。
Anticancer Res. 2002 Nov-Dec;22(6B):3737-41.
10
Prognostic value of DNA ploidy in breast cancer stage I-II.I-II期乳腺癌中DNA倍体的预后价值
Neoplasma. 1997;44(2):127-32.

引用本文的文献

1
Silencing of E2F3 suppresses tumor growth of Her2+ breast cancer cells by restricting mitosis.E2F3基因沉默通过限制有丝分裂来抑制Her2+乳腺癌细胞的肿瘤生长。
Oncotarget. 2015 Nov 10;6(35):37316-34. doi: 10.18632/oncotarget.5686.
2
Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors.白种人和非裔美国女性乳腺癌治疗结果的差异:一种描述生物学和非生物学因素关系的模型
Breast Cancer Res. 2013 Jun 27;15(3):208. doi: 10.1186/bcr3429.
3
Preoperative assessment of prognostic factors in breast cancer.
乳腺癌预后因素的术前评估。
J Clin Pathol. 2001 Jan;54(1):20-4. doi: 10.1136/jcp.54.1.20.
4
Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer.流式细胞术检测的DNA超四倍体与乳腺癌预后不良特征相关。
J Clin Pathol. 1997 Jul;50(7):591-5. doi: 10.1136/jcp.50.7.591.
5
S-phase fraction identifies high-risk subgroups among DNA-diploid breast cancers.S期分数可识别DNA二倍体乳腺癌中的高危亚组。
Breast Cancer Res Treat. 1996;38(3):265-75. doi: 10.1007/BF01806145.
6
Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy.乳腺癌预后标志物——凝集素HPA的结合与组织学分级、增殖细胞核抗原标记指数及倍体之间的关系。
Breast Cancer Res Treat. 1993;25(3):247-56. doi: 10.1007/BF00689839.
7
DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast.DNA细胞计量学共识会议。关于DNA细胞计量学在乳腺癌临床应用的共识性综述。
Breast Cancer Res Treat. 1993 Oct;28(1):55-9. doi: 10.1007/BF00666357.
8
DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.
Breast Cancer Res Treat. 1994;29(3):297-306. doi: 10.1007/BF00666484.
9
DNA index and S phase fraction in uveal malignant melanomas.葡萄膜恶性黑色素瘤中的DNA指数和S期分数
Br J Ophthalmol. 1995 Jun;79(6):521-6. doi: 10.1136/bjo.79.6.521.
10
Tumour aneuploidy, prognostic parameters and survival in primary breast cancer.原发性乳腺癌中的肿瘤非整倍体、预后参数与生存情况
Br J Cancer. 1987 Apr;55(4):449-54. doi: 10.1038/bjc.1987.88.